Investigational Drug LMTX as a Glimmer of Hope for Alzheimer’s in Phase III Trials
According to recently presented study at the Alzheimer’s Association International Conference 2016, researchers have completed the first recorded phase III
Read moreTau
In Novel Study Investigators Discover Potential Drug Target for Frontotemporal Dementia
Frontotemporal dementia is projected to account for about 10-15% of all dementia cases in the United States, with the greater
Read more